The Karakiewicz nomogram is the most useful clinical predictor for survival outcomes in patients with localized renal cell carcinoma

Cancer

Volumn 117, Issue 23, 2011, Pages 5314-5324

  Tan, Min Han ^a,b   Li, Huihua ^c   Choong, Caroline Victoria ^a   Chia, Kee Seng ^b   Toh, Chee Keong ^a   Tang, Tiffany ^a   Tan, Puay Hoon ^c   Wong, Chin Fong ^c   Lau, Weber ^c   Cheng, Christopher ^c  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

adjuvant chemotherapy; algorithms; decision curve analysis; likelihood functions; nomograms; prognosis; renal cell carcinoma; sorafenib; sunitinib

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CALIBRATION; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; NOMOGRAM; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; LIKELIHOOD FUNCTIONS; MALE; MIDDLE AGED; NOMOGRAMS; RETROSPECTIVE STUDIES;

EID: 80053960396     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26193     Document Type: Article

References (30)

1. Eisen T,. Adjuvant therapy in renal cell carcinoma: where are we? Eur Urol. 2007; 6 (suppl): 492-498. (Pubitemid 46216191)
2. Lane BR, Kattan MW,. Prognostic models and algorithms in renal cell carcinoma. Urol Clin North Am. 2008; 35: 613-625; vii.
3. Cindolo L, Patard J, Chiodini P, et al. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study. Cancer. 2005; 104: 1362-1371. (Pubitemid 41356151)
4. Kattan MW,. Do we need more nomograms for predicting outcomes in patients with prostate cancer? Nat Clin Pract Urol. 2008; 5: 366-367.
5. Galfano A, Novara G, Iafrate M, et al. Mathematical models for prognostic prediction in patients with renal cell carcinoma. Urol Int. 2008; 80: 113-123. (Pubitemid 351440502)
6. Di Blasio CJ, Rhee AC, Cho D, Scardino PT, Kattan MW,. Predicting clinical end points: treatment nomograms in prostate cancer. Semin Oncol. 2003; 30: 567-586. (Pubitemid 37296784)
7. Liu Z, Lv J, Ding K, Fu Q, Cao Q, Wang F,. Validation of the current prognostic models for nonmetastatic renal cell carcinoma after nephrectomy in Chinese population: a 15-year single center experience. Int J Urol. 2009; 16: 268-273.
8. Morgan TM, Elashoff RM,. Effect of covariate measurement error in randomized clinical trials. Stat Med. 1987; 6: 31-41. (Pubitemid 17017357)
9. Galfano A, Novara G, Iafrate M, et al. Mathematical models for prognostic prediction in patients with renal cell carcinoma. Urol Int. 2008; 80: 113-123. (Pubitemid 351440502)
10. Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P,. A postoperative prognostic nomogram for renal cell carcinoma. J Urol. 2001; 166: 63-67. (Pubitemid 32565343)
11. Karakiewicz PI, Briganti A, Chun FK, et al. Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol. 2007; 25: 1316-1322. (Pubitemid 46706877)
12. Sorbellini M, Kattan M, Snyder M, et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol. 2005; 173: 48-51. (Pubitemid 39627669)
13. Tan MH, Kanesvaran R, Li H, et al. Comparison of the UCLA Integrated Staging System and the Leibovich score in survival prediction for patients with nonmetastatic clear cell renal cell carcinoma. Urology. 2010; 75: 1365-1370;e1361-1363.
14. Edge S, Page, DL, Balch CM, Fleming ID, Morrow M, eds. AJCC cancer staging manual. 6th ed. New York, NY: Springer-Verlag; 2002.
15. Patard J, Leray E, Rodriguez A, Rioux-Leclercq N, Guille F, Lobel B,. Correlation between symptom graduation, tumor characteristics and survival in renal cell carcinoma. Eur Urol. 2003; 44: 226-232. (Pubitemid 36917008)
16. Al-Radi OO, Harrell FE Jr, Caldarone CA, et al. Case complexity scores in congenital heart surgery: a comparative study of the Aristotle Basic Complexity score and the Risk Adjustment in Congenital Heart Surgery (RACHS-1) system. J Thorac Cardiovasc Surg. 2007; 133: 865-875. (Pubitemid 46435924)
17. Harrell FE,. Regression modelling strategies: with applications to linear models, logistic regression and survival analysis. New York, NY: Springer-Verlag; 2001.
18. Leibovich BC, Blute ML, Cheville JC, et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer. 2003; 97: 1663-1671. (Pubitemid 36350710)
19. Vickers AJ, Cronin AM, Kattan MW, et al. Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach. Cancer. 2009; 115: 5460-5469.
20. Paoletti X, Oba K, Burzykowski T, et al. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA. 2010; 303: 1729-1737.
21. Baddi L, Benson A 3rd,. Adjuvant therapy in stage II colon cancer: current approaches. Oncologist. 2005; 10: 325-331. (Pubitemid 40647250)
22. Seruga B, Hertz PC, Wang L, et al. Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer. Ann Oncol. 2010; 21: 1411-1418.
23. Motzer R, Hutson T, Tomczak P, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med. 2007; 356: 115-124. (Pubitemid 46089672)
24. Kattan MW,. Editorial comment. Urology. 2010; 75: 1371; author reply 1371-1372.
25. Chun FK, Karakiewicz PI, Briganti A, et al. A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer. BJU Int. 2007; 99: 794-800. (Pubitemid 46439569)
26. Kattan MW,. Comparison of Cox regression with other methods for determining prediction models and nomograms. J Urol. 2003; 170: S6-9; discussion S10.
27. Kattan MW,. Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer. Curr Opin Urol. 2003; 13: 111-116. (Pubitemid 36288341)
28. Shariat SF, Karakiewicz PI, Palapattu GS, et al. Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin Cancer Res. 2006; 12: 6663-6676. (Pubitemid 44876834)
29. Shariat SF, Karakiewicz PI, Suardi N, Kattan MW,. Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature. Clin Cancer Res. 2008; 14: 4400-4407.
30. Tan MH, BT T,. Gene expression profiling predicts survival in clear cell renal cell carcinoma. Proc Am J Soc Clin Oncol. 2005.